Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blosozumab Dose-Finding Study in Postmenopausal Women with Low BMD
NCT01144377Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2010
- Primary completion
- May 2012
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of blosozumab in osteoporosis, sponsored by Eli Lilly and Company. Started Aug 2010; status: completed.
02
Drugs
blosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01144377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144377.